← Back to Clinical Trials
Recruiting NCT07888959

NCT07888959 Adapted Boxing and Photography in Haematology: Body Image and Self-Esteem

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07888959
Status Recruiting
Phase —
Sponsor University Hospital, Strasbourg, France
Condition Haematological Cancer
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2026-09-08
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
adapted boxing session

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2026-09-08 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Although the benefits of adapted physical activity (APA) are well documented in the scientific literature, few studies have specifically examined the impact of adapted boxing on body image and self-esteem in patients with haematological conditions. The current approach relies on the empirical observations of healthcare professionals, but no systematic evaluation has been conducted to quantify the actual effects of this practice on patients. This project therefore aims to address this lack of data by rigorously and scientifically assessing the impact of a boxing session on patients' psychological and emotional well-being. The use of validated questionnaires (Rosenberg Scale, QIC, EORTC QLQ-C30) will provide objective and comparable measures12.

Eligibility Criteria

Inclusion Criteria: 1. Patients aged 18 or over 2. Patients diagnosed with cancer currently undergoing treatment in a haematology department (e.g. leukaemia, lymphoma, multiple myeloma, etc.), at various stages of their treatment journey 3. Patients considered sufficiently stable to undertake adapted physical activity following medical assessment (no medical contraindications to practising adapted boxing) and for whom it is offered as part of their standard care 4. Patients who have given their consent to participate in the study 5. Patients covered by a statutory health insurance scheme 6. Patients who have been prescribed adapted physical activity by a doctor Exclusion Criteria: 1. Minors 2. Individuals subject to a court-ordered protective measure (judicial protection order, guardianship, curatorship, etc.) 3. Inability to provide the individual with informed consent (difficulties in understanding, insufficient command of French, etc.) 4. Patients with neurological or psychiatric disorders, including severe depression 5. Pregnant women (this criterion will be recorded based on the patient's statement) 6. Breastfeeding women

Contact & Investigator

Central Contact

Cécile SONNTAG, Doctor

✉ cecile.sonntag@chru-strasbourg.fr

📞 +33 368767301

Frequently Asked Questions

Who can join the NCT07888959 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Haematological Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07888959 currently recruiting?

Yes, NCT07888959 is actively recruiting participants. Contact the research team at cecile.sonntag@chru-strasbourg.fr for enrollment information.

Where is the NCT07888959 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07888959 clinical trial?

NCT07888959 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology